These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 21289257

  • 1. Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar States.
    Balanescu S, Kopp P, Gaskill MB, Morgenthaler NG, Schindler C, Rutishauser J.
    J Clin Endocrinol Metab; 2011 Apr; 96(4):1046-52. PubMed ID: 21289257
    [Abstract] [Full Text] [Related]

  • 2. Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects.
    Szinnai G, Morgenthaler NG, Berneis K, Struck J, Müller B, Keller U, Christ-Crain M.
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3973-8. PubMed ID: 17635944
    [Abstract] [Full Text] [Related]

  • 3. An abnormal apelin/vasopressin balance may contribute to water retention in patients with the syndrome of inappropriate antidiuretic hormone (SIADH) and heart failure.
    Blanchard A, Steichen O, De Mota N, Curis E, Gauci C, Frank M, Wuerzner G, Kamenicky P, Passeron A, Azizi M, Llorens-Cortes C.
    J Clin Endocrinol Metab; 2013 May; 98(5):2084-9. PubMed ID: 23515451
    [Abstract] [Full Text] [Related]

  • 4. Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment.
    Zittema D, Boertien WE, van Beek AP, Dullaart RP, Franssen CF, de Jong PE, Meijer E, Gansevoort RT.
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):906-13. PubMed ID: 22516290
    [Abstract] [Full Text] [Related]

  • 5. Release and Decay Kinetics of Copeptin vs AVP in Response to Osmotic Alterations in Healthy Volunteers.
    Fenske WK, Schnyder I, Koch G, Walti C, Pfister M, Kopp P, Fassnacht M, Strauss K, Christ-Crain M.
    J Clin Endocrinol Metab; 2018 Feb 01; 103(2):505-513. PubMed ID: 29267966
    [Abstract] [Full Text] [Related]

  • 6. The effect of a highly specific serotonin agonist on osmoregulated vasopressin secretion in healthy man.
    Faull CM, Rooke P, Baylis PH.
    Clin Endocrinol (Oxf); 1991 Nov 01; 35(5):423-30. PubMed ID: 1814657
    [Abstract] [Full Text] [Related]

  • 7. A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus.
    Fenske W, Refardt J, Chifu I, Schnyder I, Winzeler B, Drummond J, Ribeiro-Oliveira A, Drescher T, Bilz S, Vogt DR, Malzahn U, Kroiss M, Christ E, Henzen C, Fischli S, Tönjes A, Mueller B, Schopohl J, Flitsch J, Brabant G, Fassnacht M, Christ-Crain M.
    N Engl J Med; 2018 Aug 02; 379(5):428-439. PubMed ID: 30067922
    [Abstract] [Full Text] [Related]

  • 8. Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients.
    Struck J, Morgenthaler NG, Bergmann A.
    Peptides; 2005 Dec 02; 26(12):2500-4. PubMed ID: 15922490
    [Abstract] [Full Text] [Related]

  • 9. Effect of intravenous and intracerebroventricular infusion of hypertonic solutions on plasma and cerebrospinal fluid vasopressin concentrations.
    Wang BC, Share L, Crofton JT, Kimura T.
    Neuroendocrinology; 1982 Mar 02; 34(3):215-21. PubMed ID: 7070592
    [Abstract] [Full Text] [Related]

  • 10. [Copeptin: diagnostic parameter, biomarker, or both?].
    Rutishauser J.
    Ther Umsch; 2009 Nov 02; 66(11):731-4. PubMed ID: 19885789
    [Abstract] [Full Text] [Related]

  • 11. Urine and plasma osmolality in patients with autosomal dominant polycystic kidney disease: reliable indicators of vasopressin activity and disease prognosis?
    Casteleijn NF, Zittema D, Bakker SJ, Boertien WE, Gaillard CA, Meijer E, Spithoven EM, Struck J, Gansevoort RT.
    Am J Nephrol; 2015 Nov 02; 41(3):248-56. PubMed ID: 25926129
    [Abstract] [Full Text] [Related]

  • 12. A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresis.
    Fenske WK, Christ-Crain M, Hörning A, Simet J, Szinnai G, Fassnacht M, Rutishauser J, Bichet DG, Störk S, Allolio B.
    J Am Soc Nephrol; 2014 Oct 02; 25(10):2376-83. PubMed ID: 24722436
    [Abstract] [Full Text] [Related]

  • 13. Water Supplementation Reduces Copeptin and Plasma Glucose in Adults With High Copeptin: The H2O Metabolism Pilot Study.
    Enhörning S, Brunkwall L, Tasevska I, Ericson U, Persson Tholin J, Persson M, Lemetais G, Vanhaecke T, Dolci A, Perrier ET, Melander O.
    J Clin Endocrinol Metab; 2019 Jun 01; 104(6):1917-1925. PubMed ID: 30566641
    [Abstract] [Full Text] [Related]

  • 14. The effect of drinking on atrial natriuretic peptide, vasopressin and thirst appreciation in hyperosmolar man.
    Burrell LM, Lambert HJ, Baylis PH.
    Clin Endocrinol (Oxf); 1991 Sep 01; 35(3):229-34. PubMed ID: 1835911
    [Abstract] [Full Text] [Related]

  • 15. Pulsatile secretion pattern of vasopressin under basal conditions, after water deprivation, and during osmotic stimulation in dogs.
    van Vonderen IK, Wolfswinkel J, Oosterlaken-Dijksterhuis MA, Rijnberk A, Kooistra HS.
    Domest Anim Endocrinol; 2004 Jul 01; 27(1):1-12. PubMed ID: 15158530
    [Abstract] [Full Text] [Related]

  • 16. Copeptin in the differential diagnosis of hyponatremia.
    Fenske W, Störk S, Blechschmidt A, Maier SG, Morgenthaler NG, Allolio B.
    J Clin Endocrinol Metab; 2009 Jan 01; 94(1):123-9. PubMed ID: 18984663
    [Abstract] [Full Text] [Related]

  • 17. Comparison between copeptin and vasopressin in a population from the community and in people with chronic kidney disease.
    Roussel R, Fezeu L, Marre M, Velho G, Fumeron F, Jungers P, Lantieri O, Balkau B, Bouby N, Bankir L, Bichet DG.
    J Clin Endocrinol Metab; 2014 Dec 01; 99(12):4656-63. PubMed ID: 25202818
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.